NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Chou R, Dana T, Blazina I, et al. Statin Use for the Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Nov. (Evidence Syntheses, No. 139.)
This publication is provided for historical reference only and the information may be out of date.
Statin Use for the Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force [Internet].
Show detailsTable 1Statin Dosing and ACC/AHA Classification of Intensity
| Statin | Dosage | ||
|---|---|---|---|
| Low-intensity (LDL-C reduction <30%) | Moderate-intensity (LDL-C reduction 30% to <50%) | High-intensity (LDL-C reduction >50%) | |
| Atorvastatin | NA | 10 to 20 mg | 40 to 80 mg |
| Fluvastatin | 20 to 40 mg | 40 mg 2×/day; XL 80 mg | NA |
| Lovastatin | 20 mg | 40 mg | NA |
| Pitavastatin | 1 mg | 2 to 4 mg | NA |
| Pravastatin | 10 to 20 mg | 40 to 80 mg | NA |
| Rosuvastatin | NA | 5 to 10 mg | 20 to 40 mg |
| Simvastatin | 10 mg | 20 to 40 mg | NA |
From ACC/AHA, 2013.30 Dosages shown are total daily dosages; exceptions are noted.
Abbreviations: ACC=American College of Cardiology; AHA=American Heart Association; LDL-C=low-density lipoprotein cholesterol; NA=not applicable.
- Table 1, Statin Dosing and ACC/AHA Classification of Intensity - Statin Use for ...Table 1, Statin Dosing and ACC/AHA Classification of Intensity - Statin Use for the Prevention of Cardiovascular Disease in Adults
- PTGS2 [Acanthisitta chloris]PTGS2 [Acanthisitta chloris]Gene ID:103807814Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...